Oracle announces another acquisition

Oracle on Friday announced plans to buy Phase Forward, which develops software for drug manufacturers, for about US $685 million. The deal is expected to close mid-year.

Phase Forward’s SaaS (software as a service) products guide the entire drug-development process, from clinical trials to monitoring after they receive regulatory approval, according to a statement. Its employees will be folded into Oracle’s Health Sciences global business unit.

The acquisition is just the latest in a long string by Oracle in recent years, but also one of the larger ones in recent history. It ties into the vendor’s desire to mine new business from vertical markets like health care.

Would you recommend this article?

Share

Thanks for taking the time to let us know what you think of this article!
We'd love to hear your opinion about this or any other story you read in our publication.


Jim Love, Chief Content Officer, IT World Canada

Featured Download

CDN Staff
CDN Staffhttps://channeldailynews.com
For over 25 years, CDN has been the voice of the IT channel community in Canada. Today through our digital magazine, e-mail newsletter, video reports, events and social media platforms, we provide channel partners with the information they need to grow their business.

Related Tech News

CDN in your inbox

CDN delivers a critical analysis of the competitive landscape detailing both the challenges and opportunities facing solution providers. CDN's email newsletter details the most important news and commentary from the channel.